MBF Healthcare Acquisition Corp
MBF Healthcare Acquisition — SPAC Merger (August 2008)
11 slides from MBF Healthcare Acquisition's SPAC merger presentation, Aug 1, 2008
Slide 1: MBF Healthcare Acquisition Corp. Acquisition of Critical Homecare Solutions
DRAFT CONFIDENTIAL MBF Healthcare Acquisition Corp. Acquisition of Critical Homecare Solutions July 2008 Healthcare Acquisition Corp.
Slide 2: Forward Looking Statements
Forward Looking Statements This presentation may include statements regarding anticipated and future developments that are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those contained in forward-loo
Slide 3: Additional Information & Participants in Solicitation
Additional Information & Participants in Solicitation Additional Information and Where to Find It On June 3, 2008, MBH filed an amended preliminary proxy statement concerning the proposed transaction, which is subject to review by the Securities and Exchange Commission. MBH stockholders and other in
Slide 4: Overview of Critical Homecare Solutions
Healthcare Acquisition Corp. Overview of Critical Homecare Solutions Local business model serving 16,000 patients with 450 payor relationships Note: 1 Pro forma numbers reflect the acquisitions completed through December 31, 2007 as if they had been completed as of January 1, 2007. Wilcox acquisitio
Slide 5: Investment Highlights
Investment Highlights Healthcare Acquisition Corp.
Slide 6: Growth Strategy
Growth Strategy Healthcare Acquisition Corp. Organic Focus on high value infusion therapies (53% of infusion revenue from Tier 1 therapies) Operate local clinical model with customized care Target local and regional sources by leveraging long-standing relationships Expand payor relationships to regi
Slide 7: Overview of Restructured Transaction
Overview of Restructured Transaction Healthcare Acquisition Corp. MBF LP and the Sellers are seeking to reduce fully diluted enterprise value to create a compelling investment opportunity The fully diluted enterprise value will be significantly below the public market value upon the consummation of
Slide 8: Restructured Transaction
Restructured Transaction Healthcare Acquisition Corp. Assumes 90% approval $ in millions Source: Company filings and Company Management Deferred underwriting fees are included in this estimate and are not deducted out of the SPAC equity contribution. Assumes 16.0 million warrants are repurchased.
Slide 9: Precedent Transactions
Precedent Transactions Healthcare Acquisition Corp. Precedent Transactions There are no pure play publicly traded home infusion companies but there have been 4 significant recent transactions in the home infusion sector Source: SDC, CapitalIQ, Company press releases and SEC filings. (1) Run rate EBI
Slide 10: Fully Diluted Shares Outstanding
Fully Diluted Shares Outstanding (1) Assumes $9.0 million of MBF's $12.0 million open market purchase facility is not used and is a source in the transaction. Assumed to be contributed at $8.27 per share. Kohlberg and MBF's investment is contributed at a share price equal to the greater of the cash
Slide 11: Implied Value per Share (Fully Diluted)
Implied Value per Share (Fully Diluted) $ in millions except per share data (1) Based on Company guidance. (2) Assumes cash on Company's balance sheet at close of $0.4mm plus cash from sources. (3) Dilution is based on a warrant strike price of $6.00 and an expected cash value per share in trust at
MBF Healthcare Acquisition — SPAC Merger (August 2008) on 6ix